Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision/version label was updated from v3.5.2 to v3.5.3, indicating an interface or documentation build change rather than an update to the underlying trial study details.
    Difference
    0.0%
    Check dated 2026-04-26T15:24:44.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:37:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T17:40:17.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the prior v3.4.2 entry.
    Difference
    0.0%
    Check dated 2026-03-07T09:56:52.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; this is a minor update that does not alter study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T05:13:00.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.0 to v3.4.1. No changes to study content or page functionality.
    Difference
    0.0%
    Check dated 2026-02-06T23:31:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.